missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ SuperScript™ IV First-Strand Synthesis System

Catalog No. 18091050
Encompass
Change view
Click to view available options
Includes:
Kit only
Kit with ezDNase
No. of Reactions:
200 Reactions
50 Reactions
4 product options available for selection
Product selection table with 4 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Includes No. of Reactions
18091050 Kit only 50 Reactions
18091200 Kit only 200 Reactions
18091150 Kit with ezDNase 50 Reactions
18091300 Kit with ezDNase 200 Reactions
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 4 options available.
4 options
Catalog No. 18091050 Supplier Invitrogen™ Supplier No. 18091050
Only null left

The SuperScript IV First-Strand Synthesis System for RT-PCR, available with or without ezDNase, is optimized for synthesis of first-strand cDNA from purified poly(A)+ or total RNA.

The SuperScript IV First-Strand Synthesis System for RT-PCR, available with or without ezDNase, is optimized for synthesis of first-strand cDNA from purified poly(A)+ or total RNA. The system includes SuperScript IV Reverse Transcriptase (RT), a proprietary MMLV mutant that produces robust and reliable cDNA synthesis in RT reactions. The SuperScript IV First-Strand Synthesis System with ezDNase has the further ability to remove potential genomic DNA contamination.

The SuperScript IV synthesis system is significantly improved over the SuperScript III-based system in inhibitor resistance, processivity, and reaction speed, while retaining all the benefits of the previous system, including increased thermostability, highly efficient full-length cDNA synthesis, and reduced RNase activity. The SuperScript IV system is designed to provide reliable, consistent, and fast cDNA synthesis in the presence of inhibitors found in a wide variety of samples that cause other currently available RTs to perform inefficiently.

The extremely simplified genomic DNA removal step of the SuperScript IV First-Strand Synthesis System with ezDNase dramatically reduces the time of the entire reverse transcription protocol and reduces possible variation in gene expression due to RNA loss or damage during conventional DNase treatment. The SuperScript IV synthesis system with ezDNase is the top choice for performance and flexibility for RT-PCR applications. We recommend it for all RT-PCR applications, especially when reproducibility and reliability is the primary concern and when inhibitors in the RNA sample may interfere with cDNA synthesis, leading to biases in gene expression studies.

Both SuperScript IV First-Strand Synthesis systems contain all components needed for RT reactions, plus an additional control gene and primers, and provide the flexibility to customize the RT set-up to fit the needs of your application.

Features of the SuperScript IV First-Strand Synthesis System include:
• Significantly improved resistance to a variety of inhibitors that can interfere with cDNA synthesis
• Robust and specific cDNA synthesis in a wide range of sample types
• A faster reverse transcriptase reaction that reduces incubation time from >50 min to 10 min
• Significantly better processivity compared to SuperScript III RT
• Simplified genomic DNA removal step (SuperScript IV synthesis system with ezDNase only)

Enzyme source
Purified from E. coli expressing the pol gene of M-MLV, modified to increase thermostability, half-life, processivity, and inhibitor resistance and to reduce RNase H activity.

Performance and quality testing
Endodeoxyribonuclease, exodeoxyribonuclease, and ribonuclease assays; and yield and length of cDNA product

Unit definition
One unit of SuperScript IV RT is the amount of enzyme required to incorporate 1 nmole of deoxyribonucleotide into acid-precipitable material in 10 min at 37°C using poly(A) oligo(dT)12-18 as a template/primer.

Unit reaction conditions
50 mM Tris-HCl (pH 8.3), 4 mM MgCl2, 10 mM DTT, 50 mM KCl, 0.5 mM dTTP, 0.4 MBq/mL [3H]-dTTP, 0.4 mM poly(A) oligo (dT)12-18 and enzyme in 20 μL for 10 min at 37°C

Specifications

Content And Storage

• Oligo(dT)20 , 50 μL (50 μM)
• Random hexamers, 250 μL (50 ng/μL)
• 5X RT buffer, 1 mL
• DTT, 250 μL (0.1 M)
• dNTP mix, 250 μL (10 mM)
• SuperScript IV RT, 50 μL (200 U/μL)
• Ribonuclease Inhibitor, 100 μL (40 U/μL)
E. coli RNase H, 50 μL (2 U/μL)
• DEPC-treated water, 1.2 mL
• Total HeLa RNA, 20 μL (10 ng/μL)
• Sense Control Primer, 25 μL (10 μM)
• Antisense Control Primer, 25 μL (10 μM)

Store at -15°C to -25°C.

Format Kit
GC-Rich PCR Performance High
Reaction Speed 10 min.
Technique Reverse Transcription
Optimal Reaction Temperature 50°C
Quantity Each
Reverse Transcriptase SuperScript IV
Shipping Condition Dry Ice
For Use With (Application) RT-PCR, Real Time PCR (qPCR)
Final Product Type First-Strand cDNA
No. of Reactions 50 Reactions
Reaction Format Separate components
Reagent Type Reverse Transcription
Size (Final Product) Up to 12.3 kb
Starting Material RNA
Includes Kit only
Show More Show Less
Is it normal to see a band in the SuperScript IV First-Strand Synthesis System (Cat. Nos. 18091050, 18091200) "No Reverse Transcriptase (RT) Control"?

Yes. The SuperScript IV First-Strand Synthesis System (Cat. No. 18091050, 18091200) "No Reverse Transcriptase (RT) Control" will often display a level of amplification because of residual genomic DNA in the RNA preps. In general, you do not need to worry if a faint band shows up on a gel, as long as the intensity of the positive control is much higher.

In your SuperScript IV RT protocols, there is no ezDNase inactivation step. Will ezDNase be active to affect RNA or the RT reaction?

The Invitrogen ezDNase Enzyme is a novel DNase that is highly specific for double-stranded DNA. It has no activity on single-stranded DNA in RT reactions (primers or probes), or on RNA. The enzyme is also thermolabile—it is inactivated quickly at temperatures typical for the SuperScript IV RT reaction (e.g., 50 degrees C). The additional inactivation step is therefore not required for most RT-qPCR applications. If the RNA sample is to be used for RT-PCR of fragments ≥3 kb, incubate the sample for 5 minutes at 55 degrees C in the presence of 10 mM DTT to inactivate the enzyme.

Which SuperScript IV RT format do you recommend for real-time PCR applications?

For RT-qPCR applications we recommend using the Invitrogen SuperScript IV VILO Master Mix. The cDNA synthesis reaction setup with this master mix requires fewer pipetting steps and therefore reduces variation in the data. SuperScript IV RT, as a component of the master mix, offers the highest efficiency of cDNA synthesis step compared to competitors’ products.

Are there any significant changes in the SuperScript IV RT protocol compared to the SuperScript III RT protocol?

The only difference is that the incubation time for the reverse transcription reaction has been reduced to 10 minutes and inactivation time has been reduced to 5 minutes at 85 degrees C.

Can I get comparable cDNA yield and length using the SuperScript IV RT 10-minute protocol as when using the 50-minute protocol for SuperScript III RT?

When compared with SuperScript III RT (and other manufacturers’ RTs) in a synthesis reaction for a 9 kb cDNA, SuperScript IV RT performed successful synthesis in just 10 minutes and did so with comparable (or improved) yield (as shown by gel band density).

For real-time PCR applications, why do you recommend the SuperScript IV VILO Master Mix over the SuperScript VILO Master Mix?

For real-time PCR applications we recommend the SuperScript IV VILO Master Mix for superior performance and resistance to inhibitors.

Can Superscript IV RT be used at higher reaction temperatures to reverse transcribe targets with secondary structure?

SuperScript IV RT sustains 100% activity up to 56.4 degrees C and 70% activity up to 65 degrees C. The enzyme's ability to function at higher temperatures enables the reverse transcription of RNA targets with strong secondary structure.

What is the longest cDNA product that Superscript IV RT can synthesize?

We have found that SuperScript IV RT was able to produce a 12.3 kb cDNA product while all other reverse transcriptases tested at the same time produced smears and smaller products, using a gene-specific reverse transcription primer.

For more information about the performance of SuperScript IV, please refer to the whitepaper Whitepaper: SuperScript IV Reverse Transcriptase.

Which inhibitors has Superscript IV RT been tested with for superior performance?

SuperScript IV RT functions exceedingly better than all tested enzymes in the presence of TRIzol Reagent, ethanol, SoluLyse reagent, guanidinium salts, LiCl, ammonium acetate, hematin, and humic acid. SuperScript IV RT is also able to perform in the presence of formalin, paraffin, and isopropanol.

For more information about the performance of SuperScript IV, please refer to the white paper Whitepaper: SuperScript IV Reverse Transcriptase.

Can I use the Invitrogen SuperScript III RT/ Invitrogen SuperScript II RT 5X first-strand buffer with Invitrogen Superscript IV RT?

We do not recommend using SuperScript III RT/ SuperScript II RT 5X first-strand buffer with Superscript IV RT. For optimal performance of Superscript IV RT, we recommend using it with the 5X RT buffer supplied in the kit.

What is the composition of the 5X RT buffer supplied with Invitrogen SuperScript IV RT?

The composition of the buffer is proprietary.

What are the unique features of Invitrogen Superscript IV Reverse Transcriptase? How does it compare to Invitrogen Superscript III Reverse Transcriptase?

While retaining all the performance benefits of SuperScript III RT, SuperScript IV RT has the following additional benefits:

- Significantly improved resistance to a variety of inhibitors that can interfere with cDNA synthesis
- Robust and specific cDNA synthesis across a wide range of sample types
- Increased reproducibility
- A faster reverse transcriptase reaction time that reduces the incubation time from >50 minutes to 10 minutes
- Increased thermostability
- Significantly better processivity


For Research Use Only. Not for use in diagnostic procedures.